US Senate confirms Erica Schwartz as CDC director after year-long vacancy
Synopsis
Key Takeaways
The US Senate on Wednesday voted 51 to 44 to confirm Erica Schwartz as director of the Centers for Disease Control and Prevention (CDC), ending nearly a year-long leadership vacuum at the agency that had been managed only on an acting basis. The confirmation vote fell mostly along partisan lines.
Who Is Erica Schwartz
Schwartz brings a notable federal health pedigree to the role. She served as a rear admiral in the US Public Health Service Commissioned Corps and held the position of Deputy Surgeon General from January 2019 to April 2021 — during President Donald Trump's first term. Her confirmation makes her the Trump administration's third nominee to lead the CDC in the past two years.
A Turbulent Road to Confirmation
The CDC directorship has seen extraordinary instability. Trump's initial nominee, David Weldon — a physician and former US Representative from Florida — had his nomination withdrawn in March 2025 after it became clear he lacked sufficient Senate support.
Susan Monarez was subsequently confirmed as CDC director, but was fired by Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. in August 2025, just one month into her tenure, reportedly over disagreements on vaccine policy.
Following Monarez's removal, HHS Deputy Secretary Jim O'Neill stepped in as acting director, only to depart the department in February 2026. Jay Bhattacharya, director of the National Institutes of Health (NIH), was then appointed acting CDC chief — a stopgap arrangement that has now concluded with Schwartz's confirmation.
Challenges Awaiting the New Director
Schwartz assumes leadership of the CDC at a moment of acute public health pressure. The agency is currently managing domestic outbreaks of measles and cyclosporiasis, while simultaneously monitoring a surge in Ebola cases in Africa. Critics argue that the prolonged leadership instability has hampered the CDC's institutional capacity to respond swiftly to such threats.
What Comes Next
With a confirmed director now in place, the CDC is expected to move toward greater policy continuity after two years of churn. Whether Schwartz can stabilise the agency's internal direction — particularly on vaccine policy, which proved the flashpoint for her predecessor's dismissal — will be closely watched by public health experts and lawmakers alike.